Overview

Stem Cell Derived Exome for Treatment of Diabetic Foot

Status:
NOT_YET_RECRUITING
Trial end date:
2033-12-30
Target enrollment:
Participant gender:
Summary
This trial is designed to investigate the safety and efficacy of patients with diabetic foot by using stem cell derived exome.
Phase:
PHASE1
Details
Lead Sponsor:
Second Affiliated Hospital of Guangzhou Medical University